(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a U.S.-based pharmaceutical company, reported a wider loss in the second quarter.
The company reported a net loss of $17.7 million or $1.44 per share in the second quarter of 2025, compared to a net loss of $10 million or $0.90 per share.
The rise in losses during this quarter was caused by increased operating expenses, particularly driven by higher clinical development expenses.
Tuesday, CRBP closed at $8.90, down 4.71%, and is trading flat after hours on the NasdaqCM.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
